The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting.
Cancer Manag Res
; 13: 7747-7757, 2021.
Article
in En
| MEDLINE
| ID: mdl-34675670
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancer Manag Res
Year:
2021
Type:
Article
Affiliation country:
Italy